Diagnostic intelligence only creates value if teams can actually activate clinical cohorts. Too often, precision strategies stall at onboarding slowed by identity gaps, compliance concerns, and operational friction. By combining Diaceutics clinical audiences with Throtles privacy first identity resolution, pharma teams can move from insight to activation without friction, turning precision from a promise into something teams can confidently use at scale.
In pharma marketing, diagnostic intelligence is only as valuable as a team’s ability to activate it. Yet this is where even the most advanced precision strategies often falter. Clinical cohorts are defined, insights are surfaced, but activation stalls slowed by identity gaps, onboarding delays, privacy concerns, and operational friction that keeps programs from ever reaching their full potential.
The Diaceutics + Throtle partnership changes that.
Diagnostic driven audiences are only powerful if they can be connected to the right healthcare professionals (HCPs) in a compliant, scalable way. By integrating Diaceutics’ clinical and diagnostic audience intelligence with Throtle’s privacy first identity resolution, pharma teams can now move from insight to activation seamlessly without the bottlenecks that typically undermine precision execution.
‑driven audiences are only powerful if they can be connected to the right healthcare professionals (HCPs) in a compliant, scalable way. By integrating Diaceutics’ clinical and diagnostic audience intelligence with ‑first identity resolution, pharma teams can now move from insight to activation seamlessly
Why Precision Breaks at Activation
Most pharma marketers know this story well:
- Audience design is rich and clinically aligned, often rooted in genomics, lab results, and real world diagnostic patterns.‑world diagnostic patterns.
- But identity data lags behind, leaving marketers unable to match those insights to real, reachable HCPs or to do so in a compliant, privacy safe way.‑safe way.
- The result? Activation is fragmented, delayed, or scaled back precision promise in, blunt execution out.
This bottleneck represents the single biggest barrier between what precision could deliver and what actually reaches the field.
Where Diaceutics + Throtle Close the Gap
The collaboration brings together two complementary strengths:
1. Diaceutics: Diagnosticm Powered Clinical Audience Intelligence‑Powered Clinical Audience Intelligence
With deep laboratory, genomic, claims, EHR, and pharmacy data, Diaceutics builds clinical cohorts focused on true patient journeys at the molecular level. These audiences deliver the precision marketers need for effective omnichannel execution.
2. Throtle: Privacy First Healthcare Identity Resolution‑First Healthcare Identity Resolution
Throtle unifies fragmented identity data - securely and compliantly - connecting clinical insights to verified HCP identities and digital channels.
Together, these capabilities make precision audiences usable, activatable, and scalable.
Turning Insights Into Confident Activation
With a single, integrated solution, pharma marketers can now:
- Resolve identity gaps that traditionally slow onboarding
- Activate clinical segments without compliance trade-offs
- Reach HCPs across channels with more accuracy and less friction
- Execute omnichannel programs that actually reflect clinical reality
This collaboration fundamentally reshapes how brands connect with healthcare providers across digital channels. Throtle’s identity layer ensures that even highly advanced diagnostic based cohorts translate directly into actionable, measurable HCP audiences.
‑based cohorts translate directly into actionable, measurable HCP audiences.
Precision Moves From Promise to Practice
For pharma marketers under pressure to personalize, differentiate, and prove impact, the Diaceutics + Throtle partnership removes the biggest barrier to success: the activation gap.
When clinical cohort design and privacy first identity resolution finally work together, precision medicine marketing stops being aspirational and becomes operational.‑first identity resolution finally work together, precision medicine marketing stops being aspirational
Insight without friction. Activation without hesitation. Precision without limits.
Register your interest in Diaceutics Audiences here to receive more information: Contact Us - Diaceutics
